Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia

Clinical trial NCT05641142 · RECRUITING

Trial details

NCT number: NCT05641142
Sponsor: University Hospital, Clermont-Ferrand
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Hereditary Hemorrhagic Telangiectasia Rendu Osler Disease

Start date: 2023-04-07
Primary completion: 2029-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.